These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 28442435)

  • 1. Effectiveness of rotavirus pentavalent vaccine under a universal immunization programme in Israel, 2011-2015: a case-control study.
    Muhsen K; Anis E; Rubinstein U; Kassem E; Goren S; Shulman LM; Ephros M; Cohen D
    Clin Microbiol Infect; 2018 Jan; 24(1):53-59. PubMed ID: 28442435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of rotavirus gastroenteritis hospitalizations and genotypes, before and five years after introducing universal immunization in Israel.
    Muhsen K; Kassem E; Rubenstein U; Goren S; Ephros M; Cohen D; Shulman LM
    Vaccine; 2016 Nov; 34(48):5916-5922. PubMed ID: 27771186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-World Effectiveness of Pentavalent Rotavirus Vaccine Among Bedouin and Jewish Children in Southern Israel.
    Leshem E; Givon-Lavi N; Tate JE; Greenberg D; Parashar UD; Dagan R
    Clin Infect Dis; 2016 May; 62 Suppl 2():S155-60. PubMed ID: 27059350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of rotavirus vaccine on all-cause acute gastroenteritis and rotavirus hospitalizations in Israel: A nationwide analysis.
    Muhsen K; Haklai Z; Applbaum Y; Gordon ES; Shteiman A; Glatman-Freedman A; Leshem E
    Vaccine; 2020 Feb; 38(10):2406-2415. PubMed ID: 32029322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rotavirus vaccines in Israel: Uptake and impact.
    Muhsen K; Cohen D
    Hum Vaccin Immunother; 2017 Jul; 13(7):1722-1727. PubMed ID: 28281866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A significant and consistent reduction in rotavirus gastroenteritis hospitalization of children under 5 years of age, following the introduction of universal rotavirus immunization in Israel.
    Muhsen K; Rubenstein U; Kassem E; Goren S; Schachter Y; Kremer A; Shulman LM; Ephros M; Cohen D
    Hum Vaccin Immunother; 2015; 11(10):2475-82. PubMed ID: 26212174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact and effectiveness of RotaTeq® vaccine based on 3 years of surveillance following introduction of a rotavirus immunization program in Finland.
    Vesikari T; Uhari M; Renko M; Hemming M; Salminen M; Torcel-Pagnon L; Bricout H; Simondon F
    Pediatr Infect Dis J; 2013 Dec; 32(12):1365-73. PubMed ID: 24051998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of monovalent and pentavalent rotavirus vaccines in Japanese children.
    Araki K; Hara M; Tsugawa T; Shimanoe C; Nishida Y; Matsuo M; Tanaka K
    Vaccine; 2018 Aug; 36(34):5187-5193. PubMed ID: 30037664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of rotavirus vaccines for prevention of rotavirus gastroenteritis-associated hospitalizations in Israel: a case-control study.
    Muhsen K; Shulman L; Kasem E; Rubinstein U; Shachter J; Kremer A; Goren S; Zilberstein I; Chodick G; Ephros M; Cohen D
    Hum Vaccin; 2010 Jun; 6(6):450-4. PubMed ID: 20448471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained High Effectiveness of RotaTeq on Hospitalizations Attributable to Rotavirus-Associated Gastroenteritis During 4 Years in Finland.
    Hemming-Harlo M; Vesikari T; Uhari M; Renko M; Salminen M; Torcel-Pagnon L; Hartwig S; Simondon F; Bricout H
    J Pediatric Infect Dis Soc; 2017 Nov; 6(4):317-323. PubMed ID: 27760800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact and effectiveness of pentavalent rotavirus vaccine in children <5 years of age in Burkina Faso.
    Bonkoungou IJO; Aliabadi N; Leshem E; Kam M; Nezien D; Drabo MK; Nikiema M; Ouedraogo B; Medah I; Konaté S; Ouédraogo-Traoré R; Sangaré L; Kam L; Yé D; Ouattara M; Biey JN; Mwenda JM; Tate JE; Parashar UD
    Vaccine; 2018 Nov; 36(47):7170-7178. PubMed ID: 29290478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Burden of paediatric Rotavirus Gastroenteritis (RVGE) and potential benefits of a universal Rotavirus vaccination programme with a pentavalent vaccine in Spain.
    Diez-Domingo J; Suriñach NL; Alcalde NM; Betegón L; Largeron N; Trichard M
    BMC Public Health; 2010 Aug; 10():469. PubMed ID: 20698958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States.
    Boom JA; Tate JE; Sahni LC; Rench MA; Hull JJ; Gentsch JR; Patel MM; Baker CJ; Parashar UD
    Pediatrics; 2010 Feb; 125(2):e199-207. PubMed ID: 20083525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of Pentavalent Rotavirus Vaccine Against a Diverse Range of Circulating Strains in Nicaragua.
    Patel M; Pedreira C; De Oliveira LH; Tate J; Leshem E; Mercado J; Umaña J; Balmaceda A; Reyes M; Kerin T; McDonald S; Gentsch J; Bowen MD; Parashar U
    Clin Infect Dis; 2016 May; 62 Suppl 2():S127-32. PubMed ID: 27059346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spotlight on pentavalent rotavirus vaccine (RotaTeq) in the prevention of rotavirus gastroenteritis in Europe.
    Plosker GL
    BioDrugs; 2010 Dec; 24(6):411-4. PubMed ID: 21043548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of the monovalent G1P[8] human rotavirus vaccine against hospitalization for severe G2P[4] rotavirus gastroenteritis in Belém, Brazil.
    Justino MC; Linhares AC; Lanzieri TM; Miranda Y; Mascarenhas JD; Abreu E; Guerra SF; Oliveira AS; da Silva VB; Sanchez N; Meyer N; Shafi F; Ortega-Barria E; Soriano-Gabarró M; Colindres RE
    Pediatr Infect Dis J; 2011 May; 30(5):396-401. PubMed ID: 21150692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pentavalent rotavirus vaccine (RotaTeq): a review of its use in the prevention of rotavirus gastroenteritis in Europe.
    Plosker GL
    Drugs; 2010 Jun; 70(9):1165-88. PubMed ID: 20518582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No evidence of an increase in the incidence of norovirus gastroenteritis hospitalizations in young children after the introduction of universal rotavirus immunization in Israel.
    Muhsen K; Kassem E; Rubenstein U; Goren S; Ephros M; Shulman LM; Cohen D
    Hum Vaccin Immunother; 2019; 15(6):1284-1293. PubMed ID: 30945960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of rotavirus vaccines in preventing cases and hospitalizations due to rotavirus gastroenteritis in Navarre, Spain.
    Castilla J; Beristain X; Martínez-Artola V; Navascués A; García Cenoz M; Alvarez N; Polo I; Mazón A; Gil-Setas A; Barricarte A
    Vaccine; 2012 Jan; 30(3):539-43. PubMed ID: 22122860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of Pentavalent Rotavirus Vaccine Under Conditions of Routine Use in Rwanda.
    Tate JE; Ngabo F; Donnen P; Gatera M; Uwimana J; Rugambwa C; Mwenda JM; Parashar UD
    Clin Infect Dis; 2016 May; 62 Suppl 2():S208-12. PubMed ID: 27059358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.